{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:15:37Z","timestamp":1778681737280,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fm0108008"],"award-info":[{"award-number":["JP18fm0108008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["16K18792"],"award-info":[{"award-number":["16K18792"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["18K07135"],"award-info":[{"award-number":["18K07135"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["17K15367"],"award-info":[{"award-number":["17K15367"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.02.057","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T08:39:57Z","timestamp":1552034397000},"page":"2158-2166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza"],"prefix":"10.1016","volume":"37","author":[{"given":"Toshiki","family":"Sekiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edin J","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Sasada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Daito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shingai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotarou","family":"Mitsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Motokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena E","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Kino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.057_b0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrmicro1482","article-title":"Influenza pandemic vaccines: how to ensure a low-cost, low-dose option","volume":"4","author":"Stohr","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0015","first-page":"68","article-title":"Immunosenescence and challenges of vaccination against influenza in the aging population","volume":"3","author":"Reber","year":"2012","journal-title":"Aging Disease"},{"key":"10.1016\/j.vaccine.2019.02.057_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/pgmj.52.608.360","article-title":"Preparation and properties of a novel influenza subunit vaccine","volume":"52","author":"Bachmayer","year":"1976","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2019.02.057_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S002217240002458X","article-title":"Surface-antigen influenza vaccine.1. Purification of hemagglutinin and neuraminidase proteins","volume":"77","author":"Brady","year":"1976","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2019.02.057_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0022172400024591","article-title":"Surface-antigen influenza vaccine.2. Pyrogenicity and antigenicity","volume":"77","author":"Brady","year":"1976","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2019.02.057_b0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0040","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/j.2040-4603.2014.tb00544.x","article-title":"Fever, immunity, and molecular adaptations","volume":"4","author":"Hasday","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0050","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.1968.03150100027005","article-title":"Purified influenza virus vaccine - a study of viral reactivity and antigenicity","volume":"206","author":"Peck","year":"1968","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2019.02.057_b0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1542\/peds.69.4.404","article-title":"Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months","volume":"69","author":"Bernstein","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.02.057_b0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatric Infect Disease J"},{"key":"10.1016\/j.vaccine.2019.02.057_b0065","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.vaccine.2004.02.030","article-title":"Poor immune responses to influenza vaccination in infants","volume":"22","author":"Kumagai","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0070","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.057_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.aje.a112273","article-title":"Comparative trial of influenza vaccines.2. Adverse reactions in children and adults","volume":"104","author":"Barry","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"Lin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.02.057_b0090","doi-asserted-by":"crossref","first-page":"S722","DOI":"10.1093\/infdis\/136.Supplement_3.S722","article-title":"Summary of clinical-trials of influenza-virus vaccines in adults","volume":"136","author":"Parkman","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.057_b0095","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(03)15014-3","article-title":"Safety and antigenicity of whole virus and subunit influenza A\/Hong Kong\/1073\/99 (H9N2) vaccine in healthy adults: phase I randomised trial","volume":"362","author":"Stephenson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.02.057_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0042-6822(82)90375-0","article-title":"Biological-activity of monoclonal-antibodies to operationally defined antigenic regions on the hemagglutinin molecule oF A\/Seal Massachusetts\/1\/80 (H7N7) influenza-virus","volume":"122","author":"Kida","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.02.057_b0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature08596","article-title":"Central control of fever and female body temperature by RANKL\/RANK","volume":"462","author":"Hanada","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.02.057_b0110","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/317513","article-title":"Circulating cytokines as mediators of fever","volume":"31","author":"Netea","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.057_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.183.1.311","article-title":"Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipolysaccharide or IL-1 beta: A study on IL-6-deficient mice","volume":"183","author":"Chai","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.02.057_b0120","first-page":"48","article-title":"Delineation of the proinflammatory cytokine cascade in fever induction","volume":"856","author":"Zetterstrom","year":"1998","journal-title":"Mol Mech Fever"},{"key":"10.1016\/j.vaccine.2019.02.057_b0125","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.4049\/jimmunol.1600046","article-title":"Whole-virion influenza vaccine recalls an early burst of high-affinity memory B cell response through TLR signaling","volume":"196","author":"Onodera","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0130","first-page":"7","article-title":"Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02","volume":"2012","author":"Arikata","year":"2009","journal-title":"Plos One"},{"key":"10.1016\/j.vaccine.2019.02.057_b0135","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1016\/j.vaccine.2010.07.008","article-title":"Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial","volume":"28","author":"Wu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.vaccine.2009.10.067","article-title":"Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques","volume":"28","author":"Itoh","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0684.2009.00395.x","article-title":"Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non-human primate mixed infection model","volume":"39","author":"Miyake","year":"2010","journal-title":"J Med Primatol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0150","first-page":"4","article-title":"Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling","author":"Geeraedts","year":"2008","journal-title":"Plos Pathogens"},{"key":"10.1016\/j.vaccine.2019.02.057_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"Geeraedts","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.02.057_b0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2567.2007.02745.x","article-title":"Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin","volume":"124","author":"Sawai","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.02.057_b0165","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1016\/j.vaccine.2006.05.040","article-title":"The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB\/c mice","volume":"24","author":"Cox","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.057_b0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-065X.2008.00731.x","article-title":"Pattern recognition receptors and control of adaptive immunity","volume":"227","author":"Palm","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.02.057_b0175","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc Nat Acad Sci United States Am"},{"key":"10.1016\/j.vaccine.2019.02.057_b0180","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.02.057_b0185","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.4049\/jimmunol.173.10.5935","article-title":"Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus","volume":"173","author":"Hornung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.02.057_b0195","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI1355","article-title":"Local and systemic cytokine responses during experimental human influenza A virus infection - Relation to symptom formation and host defense","volume":"101","author":"Hayden","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.02.057_b0200","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.02.057_b0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(96)00575-6","article-title":"Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever","volume":"733","author":"Cao","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.vaccine.2019.02.057_b0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.20052","article-title":"Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactiviity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli","volume":"472","author":"Konsman","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.vaccine.2019.02.057_b0215","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1523\/JNEUROSCI.18-16-06279.1998","article-title":"Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies","volume":"18","author":"Matsumura","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2019.02.057_b0220","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1523\/JNEUROSCI.21-08-02669.2001","article-title":"Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever","volume":"21","author":"Yamagata","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2019.02.057_b0225","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/en.2012-1375","article-title":"Lipopolysaccharide-induced fever depends on prostaglandin E2 production specifically in brain endothelial cells","volume":"153","author":"Engstrom","year":"2012","journal-title":"Endocrinology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:23Z","timestamp":1778679083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19302646"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}